Tremfya on The Rest Is Classified

The Rest Is ClassifiedJuly 12, 2026

175. How China Downed a US Spy Plane (Ep 1)

1:03
mid-roll
David McCloskey, Gordon Corera
Goalhanger
July 12, 2026
Announcer-readBrand awarenessBaked-in adHealthcare
0:00 / 1:03
@ 3:04 in ep

Transcript

For adults with Crohn's disease or ulcerative colitis symptoms, every choice matters. Tremphaya offers self-injection or intravenous infusion from the start. Tremphaya is administered as injections under the skin or infusions through a vein every four weeks, followed by injections under the skin every four or eight weeks. If your doctor decides that you can self-inject Tremphaya, proper training is required. Tremphaya is a prescription medicine used to treat adults with moderately to severely active Crohn's disease and adults with moderately to severely active ulcerative colitis. Serious allergic reactions, increased risk of infections or lower ability to fight them, and liver problems may occur. Before treatment, get checked for infections and tuberculosis. Tell your doctor if you have an infection, flu-like symptoms, or need a vaccine. Explore what's possible. Ask your doctor about Trimphia today. Call 1-800-526-7736 to learn more or visit trimphiaradio.com.

Auto-transcribed · verbatim audio matches · Report an error

More from this campaign

Tremfya: Prescription medicine for adults with moderately to severely active Crohn's… · Feb 22–Jul 12, 2026

4 promos

More from Tremfya

Recent reads from this sponsor outside this campaign

4 promos

Estimated ad cost

~$240range $36$1,700

Estimate of what a similar one-episode podcast ad would cost based on rank, placement, and duration

Methodology and limitations →
Part of campaign

Tremfya: Prescription medicine for adults with moderately to severely active Crohn's… · Feb 22–Jul 12, 2026

Tremfya is a prescription medicine for adults with moderately to severely active Crohn's disease or ulcerative colitis.

29 promos·11 shows

Episode

The Rest Is Classified
175. How China Downed a US Spy Plane (Ep 1)
Hosts: David McCloskey, Gordon Corera
Publisher: Goalhanger